GlassScriptPhysician profile
Lowell Mccauley
NPI 1003850280
$21,286.15
in general payments reported to CMS, 2019-2025
23 companies · $856 in 2025
The $856 reported for 2025 was more than what 86% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,174 · 2020: $52.10 · 2021: $215 · 2023: $13K · 2024: $984 · 2025: $856.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Travel and Lodging: $958 · Food and Beverage: $938 · Education: $72.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,875.00 |
| Travel and Lodging | $958.31 |
| Food and Beverage | $938.43 |
| Education | $72.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $14,018.11 | 2023-2025 | Veozah |
| Asensus Surgical, INC. | $4,368.14 | 2019 | |
| Duchesnay USA Incorporated | $1,780.07 | 2019 | |
| Merz North America, INC. | $189.30 | 2021-2025 | |
| Convatec INC. | $159.12 | 2024 | |
| Medtronic, INC. | $145.42 | 2025 | Endurant Iis |
| Paratek Pharmaceuticals, INC. | $142.85 | 2024 | Nuzyra |
| Penumbra, INC. | $99.26 | 2025 | Indigo System |
| W. L. Gore & Associates, INC. | $86.27 | 2024 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Smith+Nephew, INC. | $49.80 | 2024-2025 | Collagenase Santyl, Grafix Pl, Grafix |
| Lupin INC. | $40.37 | 2020-2021 | |
| Astellas Pharma Global Development | $22.50 | 2024 | Veozah |
| Reprise Biomedical, INC. | $21.70 | 2024 | Miro3d |
| Advanced Oxygen Therapy INC. | $21.58 | 2025 | Topical Oxygen Chamber For Extremities |
| Avion Pharmaceuticals | $20.72 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $18.10 | 2025 | Novachor |
| Integra Lifesciences Corporation | $16.50 | 2021 | |
| Amgen INC. | $16.33 | 2023 | Prolia, Evenity |
| Revance Therapeutics, INC. | $15.77 | 2024 | Daxxify |
| Abbvie INC. | $15.14 | 2019 | |
| Merck Sharp & Dohme LLC | $14.95 | 2020 | |
| Amag Pharmaceuticals, INC. | $13.19 | 2020 | |
| Allergan, INC. | $10.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lowell Mccauley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.